Role of carnitine in non-alcoholic fatty liver disease and other related diseases: an update

N Li, H Zhao - Frontiers in medicine, 2021 - frontiersin.org
Carnitine is an amino acid-derived substance that coordinates a wide range of biological
processes. Such functions include transport of long-chain fatty acids from the cytoplasm to …

Influence of mitochondrion-toxic agents on the cardiovascular system

J Finsterer, P Ohnsorge - Regulatory Toxicology and Pharmacology, 2013 - Elsevier
Cardiovascular disease may be induced or worsened by mitochondrion-toxic agents.
Mitochondrion-toxic agents may be classified as those with or without a clinical effect, those …

Protective effects of olmesartan and l-carnitine on doxorubicin-induced cardiotoxicity in rats

MM Aziz, MA Abd El Fattah, KA Ahmed… - Canadian journal of …, 2020 - cdnsciencepub.com
Doxorubicin (DOX), an anthracycline antibiotic, is an important antineoplastic agent due to
its high antitumor efficacy in hematological as well as in solid malignancies. The clinical use …

Doxorubicin toxicity can be ameliorated during antioxidant L‐carnitine supplementation

OA Alshabanah, MM Hafez, MM Al-Harbi… - Oxidative Medicine …, 2010 - Wiley Online Library
Doxorubicin is an antibiotic broadly used in treatment of different types of solid tumors. The
present study investigates whether L‐carnitine, antioxidant agent, can reduce the hepatic …

Metabolic syndrome in pediatric cancer survivors: a mechanistic review

GP Rosen, HT Nguyen, GQ Shaibi - Pediatric Blood & Cancer, 2013 - Wiley Online Library
Pediatric cancer survivors have increased risk of obesity, hypertension, dyslipidemia, and
type 2 diabetes, leading to premature cardiovascular disease (CVD). Multiple tissues that …

Inhibition of gene expression of carnitine palmitoyltransferase I and heart fatty acid binding protein in cyclophosphamide and ifosfamide-induced acute cardiotoxic rat …

MM Sayed-Ahmed, ML Aldelemy… - Cardiovascular …, 2014 - Springer
This study investigated whether cyclophosphamide (CP) and ifosfamide (IFO) therapy alters
the expression of the key genes engaged in long-chain fatty acid (LCFA) oxidation outside …

PharmGKB summary: Ifosfamide pathways, pharmacokinetics and pharmacodynamics

D Lowenberg, CF Thorn, Z Desta… - Pharmacogenetics …, 2014 - journals.lww.com
Background Ifosfamide (IFO) is a widely used antitumor prodrug. It is in the
oxazaphosphorine class of DNA alkylating agents and is effective against solid tumors, such …

[HTML][HTML] Incorporating ifosfamide into salvia oil-based nanoemulsion diminishes its nephrotoxicity in mice inoculated with tumor

SM AlMotwaa, MH Alkhatib, HM Alkreathy - BioImpacts: BI, 2020 - ncbi.nlm.nih.gov
An external file that holds a picture, illustration, etc. Object name is bi-10-9-g004. jpg
Introduction: Nephrotoxicity is one of the major side effects of the chemotherapeutic drug …

Intestinal dysbiosis and development of cardiometabolic disorders in childhood cancer survivors: a critical review

S Morel, E Delvin, V Marcil, E Levy - Antioxidants & Redox …, 2021 - liebertpub.com
Significance: Survivors of pediatric cancers have a high risk of developing side effects after
the end of their treatments. Many potential factors have been associated with the onset of …

Downregulation of Oxidative and Nitrosative Apoptotic Signaling by L‐Carnitine in Ifosfamide‐Induced Fanconi Syndrome Rat Model

MM Sayed-Ahmed, MM Hafez… - Oxidative Medicine …, 2012 - Wiley Online Library
It is well documented that ifosfamide (IFO) therapy is associated with sever nephropathy in
the form of Fanconi syndrome. Although oxidative stress has been reported as a major …